The officials of Pharmacopoeia of Mexico and the US met in Mexico under the FEUM-USP Scientific Meeting 2015 to analyze and update the tests to be applied to medical devices to confirm the standardization of quality, safety and therapeutic efficacy for patients. The official from COFEPRIS, the healthcare regulatory body of Mexico, has emphasized on the significance of sharing of information and review of analytical models between the two pharmacopoeias to ensure the quality and safety of medical equipment being supplied to patients. He also mentioned that the government of Mexico is committed to update and renew the regulatory skeleton for medical devices as per the best global practices. The USP official stated that such bilateral scientific conferences are important to ensure the quality and safety of medical equipments being delivered. The Pharmacopoeial commissions of both the countries play an important role for the well-organized regulation of medical equipment to ensure the quality and safety of products. It was the fifth meeting between both the pharmacopoeias.
Pharmacopoeia professionals of Mexico & US coordinate to review and update tests for quality & safety of medical devices
GHI Analysis1 min read
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
Análise de GHI
The Top Growth Categories in Medical Equipment in Colombia for 2022
The Top Growth Categories in Medical Equipment in Colombia for 2022
Understand top growth and contraction areas to help refine your strategic planning
GHI Analysisagosto 23, 2021
News
Latin America performs well in Cancer Care, but major constraints yet to be resolved
Latin America performs well in Cancer Care, but major constraints yet to be resolved
According to the results of second commission of The Lancet Oncology, Latin America has performed…
GHI Analysisnovembro 2, 2015
News
Brazil: An opportunity for insulin pen device market growth
Brazil: An opportunity for insulin pen device market growth
Brazil, along with the US, India and China, is a transpiring country, which can be…
GHI Analysisjulho 27, 2015